Hospira Symbiq Infusion System Touchscreen: Class 1 Recall – May Not Respond to Selection

by admin on October 30, 2012

A Drug & Medical Device Recall And/Or Safety Alert Has Been Issued: Hospira Symbiq Infusion System Touchscreen: Class 1 Recall – May Not Respond to Selection. According to the Food & Drug Administration FDA’s MedWatch:

Failure of touchscreen to respond to user input could result in a delay or interruption in therapy or over delivery or under delivery of medication.

For more information on the drug or medical device recall or safety alert, read the Food & Drug Administration’s FDA’s drug or medical device recall or safety alert: Hospira Symbiq Infusion System Touchscreen: Class 1 Recall – May Not Respond to Selection.

To report an adverse reaction, problem or other issue with a drug or medical device, submit a drug or medical device complaint to the government at fda.gov or MedWatch.

If you have thoughts on the drug or medical device recall or safety alert, share your drug or medical device recall or safety alert comments below.

Share Your Recall Comments Below!

    What Do You Think? Share Your Recall Comments!

    Previous post: